Godavari Drugs
GODAVARIBSE

Godavari Drugs

₹100.002.00 (2.04%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
98.00
Today’s high
100.00
52 week low
69.70
52 week high
135.25
Open price
98.15
Previous close
98.00
Live volume
1,784
Lower circuit
80.00
Upper circuit
120.00

Fundamentals

Market Cap
₹107Cr
ROE
5.39%
P/E Ratio(TTM)
25.72
EPS(TTM)
3.81
P/B Ratio
1.38
Dividend Yield
0.00%
Industry P/E
50.91
Book Value
71.05
Debt to Equity
1.01
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
JUN '26
Revenue (Cr)
₹28.11
-15.59%
Profit (Cr)
₹1.11
-13.95%
02.25920.2536
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)+18%
3Y CAGR-11%
Profit growthValue
1Y (TTM)+7.0%
3Y CAGR-6%

About

Godavari Drugs Limited is a key player in the life science sector, specializing in manufacturing Active Pharmaceutical Ingredients (APIs), intermediates, and various fine chemicals. The company's primary vision is to establish itself as one of the leading pharmaceutical companies in India, serving clients both domestically and internationally. Its mission is centered on delivering reliable, superior quality, and cost-effective products with best-in-class delivery times, aiming to build strong, long-term customer relationships. Leveraging over three decades of experience, the company actively seeks loan license and contract manufacturing opportunities for APIs with reputed multinational partners. A core strength is its integrated capability, combining chemistry and engineering to manage product development from laboratory R&D to final commercial manufacturing. To fuel its future growth and meet rising demand, the company has recently acquired a significant 17.5-acre plot of land in Nanded for further expansion.;
CEO/MD
Mukund Kakani
Founded in
1987
BSE symbol
530317

Shareholding pattern

Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Shareholder details

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
PfizerPFIZER
₹4,703.80
-36.60 (0.77%)
L
    H
    21,702.5029.525.16
    ₹2,517.20
    -23.50 (0.92%)
    L
      H
      19,323.3128.55.39
      ₹7,106.50
      -29.50 (0.41%)
      L
        H
        17,802.75104.9520.4
        Natco PharmaNATCOPHARM
        ₹853.80
        -3.80 (0.44%)
        L
          H
          15,371.2113.431.67
          2026
          14
          Aug
          Quarterly Result
          Release date
          27
          May
          Quarterly & Annual Result
          Release date
          11
          Feb
          Result
          Release date
          2025
          14
          Nov
          Quarterly Result
          Release date
          13
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks